prostate tumor

Related by string. prostate tumors * prostates . Prostate . Prostates . PROSTATE : Prostate Specific Antigen PSA . prostate specific antigen . Prostate Cancer Charity . metastatic prostate cancer . localized prostate cancer / Tumor . Tumors . TUMOR . tumors . TUMORS : malignant brain tumor . cancerous brain tumor . battling brain tumor . brain tumor . cancerous tumor removed * *

Related by context. All words. (Click for frequent words.) 71 prostate tumors 70 tumors 68 tumor 68 prostate tissue 68 colorectal tumors 68 melanoma tumors 67 pancreatic tumor 67 tumor cells 67 pancreatic tumors 66 breast tumors 65 PCa 65 colon tumors 65 prostate cancers 65 glioblastoma cells 65 cisplatin resistant 64 PKCi 64 osteoblast 64 colorectal carcinoma 64 cancerous cells 64 HER2 protein 64 atherosclerotic lesions 64 EGF receptor 64 lung metastasis 63 colorectal tumor 63 micrometastases 63 PGE2 63 neuroblastoma cells 63 IGF 1R 63 mesothelin 63 TGF β 63 inhibit tumor 63 glioblastoma tumors 63 suppresses tumor 63 metastasis 63 lung tumors 63 malignant prostate 63 breast carcinomas 63 EGFRvIII 62 CLL cells 62 EGFr 62 ovarian tumors 62 metastatic prostate cancer 62 antitumor effect 62 B7 H3 62 HER2 expression 62 pancreatic adenocarcinoma 62 metastatic tumors 62 oncoprotein 62 prostate cancer CaP 62 LRP6 62 sarcosine 62 mammary tumors 62 myeloma cells 62 glioma cells 62 Akt1 62 factor PlGF 62 xenograft tumors 62 leukemic cells 62 cystatin C 61 tumoral 61 c MYC 61 cyclin E 61 pro angiogenic 61 OGG1 61 leukemic cell 61 PSADT 61 STAT3 61 EGFR protein 61 GSTP1 61 MDSCs 61 lymphoid cells 61 inhibited tumor 61 stromal cells 61 Ki# 61 GRP# 61 KRAS mutation 61 pancreatic cancers 61 NSCLC tumors 61 ptau 61 genistein 61 RBP4 61 GRK2 61 APOL1 61 lobular carcinoma 61 micronuclei 61 diabetic rats 61 endostatin 61 renal cell carcinomas 61 metastases 61 advanced adenomas 61 prostate carcinoma 61 malignancy 61 CCN2 60 hepatoma 60 clusterin 60 iNOS 60 EGFR 60 MetAP2 60 hematopoietic cells 60 IGF IR 60 60 breast carcinoma 60 SETDB1 60 TNFa 60 ApoA1 60 factor receptor 60 anaplastic 60 metastatic lesions 60 TNFalpha 60 androgen receptor 60 transfected cells 60 bladder tumors 60 imatinib Gleevec 60 noncancerous cells 60 Wnt#b 60 transthyretin 60 malignant cells 60 WT1 60 tumor xenografts 60 PKM2 60 oncomodulin 60 aromatase 60 inhibits tumor 60 lactate dehydrogenase 60 TNFα 60 atherosclerotic plaques 60 radiosensitivity 60 NKX#.# 60 mammary cells 60 adenoma 60 thyroglobulin 60 gene amplification 60 p#NTR 60 micrometastasis 60 EGFR receptor 60 hTERT 60 fibrocytes 60 bone metastasis 60 osteopontin 60 adipose cells 60 NQO1 60 cardiac myocytes 60 malignant transformation 60 ovarian tumor 60 EGF receptors 60 specific antigen PSA 60 LTB4 60 activin 59 S#A# [002] 59 trophoblast cells 59 pCR 59 TAp# 59 FGFR1 59 prostate specific 59 colon polyps 59 androgen independent 59 metastatic colorectal 59 PIK3CA 59 nestin 59 IL 1beta 59 Foxp3 59 GISTs 59 lymph node metastasis 59 PDGFR 59 breast cancer metastasis 59 TGF ß 59 neoplastic cells 59 alkaline phosphatase ALP 59 cathepsins 59 myeloid cells 59 inhibiting tumor 59 transgenic rats 59 SPINK1 59 liver metastases 59 microglial 59 EphA2 59 myeloperoxidase 59 VEGF receptor 59 tumor recurrence 59 DFMO 59 serum PSA 59 hypermethylation 59 BMP4 59 caveolin 1 59 monocyte 59 flavopiridol 59 uPAR 59 osteoclast 59 ErbB2 59 IGFBP 3 59 hedgehog pathway 59 RKIP 59 antiproliferative effects 59 Gleevec resistant 59 specific antigen 59 lactate dehydrogenase LDH 59 HER2 receptor 59 CD# + [001] 59 PP2A 59 vimentin 59 lymph node metastases 59 mutant protein 59 K ras mutations 59 HNSCC 59 liver metastasis 59 autoantibodies 59 P selectin 59 prostate cancer PCa 59 estrogen receptor ER 59 Immunohistochemical analysis 59 Clusterin 59 IGFBP 59 HER2 receptors 59 trophoblasts 59 RANKL 59 antigen PSA 59 MMP9 59 myocytes 59 cell carcinomas 59 beta subunit 59 leukaemic stem cells 59 elastase 59 urothelial cancer 59 survivin 59 prostate epithelial cells 59 neutrophil 59 male hormones androgens 59 RQ PCR 59 antiangiogenic 59 polyamine 59 glioblastoma 58 GATA3 58 NFkB 58 beta1 integrin 58 HER2 positive tumors 58 inhibitory effects 58 CD#c 58 RIP1 58 TGF alpha 58 VEGF expression 58 adipogenic 58 MIF protein 58 adenocarcinoma 58 PC3 cells 58 nodal metastasis 58 RANK ligand 58 neuroendocrine tumors 58 antioxidant enzyme 58 pyruvate kinase 58 platelet aggregation 58 induces apoptosis 58 Bcr Abl 58 nutlin 3a 58 carcinoembryonic antigen 58 lymphangiogenesis 58 ovarian carcinoma 58 lymphoid tissue 58 Upregulation 58 HDAC6 58 Tumors 58 PlGF 58 peritoneal carcinomatosis 58 PTEN protein 58 BRCA deficient 58 cultured cells 58 MDM2 58 basic fibroblast 58 urothelial carcinoma 58 LRP5 58 IFNg 58 lymphocytes 58 EGFR mutation 58 TGF beta pathway 58 endoglin 58 Lp PLA2 58 Akt activation 58 antigen PSA levels 58 NPY expression 58 Bcl xL 58 mononuclear cells 58 adenocarcinomas 58 mutant p# 58 seminoma 58 glioblastomas 58 microRNA miR 58 serous ovarian cancer 58 mRNA expression 58 proto oncogene 58 HER2 overexpression 58 EGFR pathway 58 HER2 positive cancers 58 fibrin deposition 58 neoadjuvant therapy 58 transgene expression 58 hypoxia inducible factor 58 ERK1 2 58 TGF ß1 58 hematopoietic stem cells 58 clonogenic 58 GBM tumors 58 mesenchymal cells 58 pDCs 58 fatty acid oxidation 58 differentiated thyroid 58 Cholangiocarcinoma 58 HGPIN 58 myoblasts 58 IgG antibodies 58 estrogen receptor alpha 58 antisense inhibition 58 eNOS 58 mutant SOD1 58 N cadherin 58 CXCL# 58 NF kappaB activation 58 FGFR2 58 castrate resistant 58 VEGFR 58 glomerular filtration 58 ADPKD 58 prognostic indicator 58 inducible nitric oxide synthase 58 AGTR1 58 4E BP1 58 medulloblastoma 58 PHD2 58 poly ADP ribose polymerase 58 prostate cancer CRPC 58 prostate cancer 58 NKT cells 58 haematopoietic 58 renal tumors 58 Glioblastoma multiforme GBM 58 oncogenic transformation 57 ERCC1 57 endometrial cancers 57 seminomas 57 lymphoid 57 VEGFb 57 follistatin 57 histone deacetylases 57 pre cancerous growths 57 chemoresistance 57 microglial activation 57 EGFR mutant 57 morphogen 57 mutated BRAF gene 57 cyclin D1 57 oxidized LDL 57 glioblastoma tumor 57 miR #b [002] 57 RRM1 57 metastatic melanomas 57 TET2 57 situ LCIS 57 E#F# 57 ferritin 57 CagA 57 cytokine interleukin 57 neurite outgrowth 57 MSMB 57 EpCAM 57 malignant growths 57 carcinoma 57 suppressor cells 57 SGK1 57 lung metastases 57 pleiotrophin 57 prostate cancer metastases 57 glucocorticoid receptor 57 complete cytogenetic response 57 VEGFR2 57 p# MAP kinase 57 somatostatin receptors 57 inflammatory cytokine 57 vWF 57 BRAF mutation 57 UCP2 57 premalignant lesions 57 Stat5 57 polyamines 57 heparanase 57 IFN gamma 57 estrogen receptor 57 anti apoptotic proteins 57 mutated KRAS 57 milatuzumab 57 vascular endothelial cells 57 pRb 57 telomerase inhibition 57 chemopreventive agent 57 Metastatic 57 CaP 57 estrogen receptors 57 esophageal adenocarcinoma 57 intratumoral injection 57 protein albumin 57 metastatic 57 keratinocyte 57 FOXO3a 57 syngeneic 57 CDK4 57 hippocampal neurons 57 Notch pathway 57 β amyloid 57 neural cells 57 palladin 57 HER2 amplification 57 progranulin 57 macrophage 57 mutant KRAS 57 TMEM#B 57 colorectal gastric 57 mesenchymal cell 57 GLI1 57 miR #a [001] 57 pulmonary metastases 57 HDAC 57 Mesenchymal 57 FLT3 57 eosinophils 57 collagenase 57 E selectin 57 IL6 57 hepatic fibrosis 57 GNAQ 57 epithelia 57 pancreatic islet 57 sFlt 1 57 colon carcinoma 57 MSH2 57 telomere lengths 57 PI3K Akt 57 cytotoxicity 57 recurrent prostate cancer 57 cancerous tissue 57 distant metastasis 57 HepG2 cells 57 IGF1 57 keratinocytes 57 renal carcinoma 57 angiogenesis inhibitor 57 stem progenitor cells 57 malignant tissue 57 paricalcitol 57 NGAL 57 pro apoptotic 57 amyloid deposits 57 tumor metastases 57 IL# [001] 57 colorectal adenocarcinoma 57 p# mutation 57 PDGF receptor 57 grade gliomas 57 factor HGF 57 neovascularization 57 mTOR inhibitors 57 malignant tumors 57 BCR ABL 57 serum prostate 57 IL 1ß 57 pancreatic 57 chitinase 57 mucinous 57 phagocyte 57 amyloid deposition 57 utrophin 57 ABCA1 57 colorectal cancer 57 5alpha reductase 57 placental cells 57 MnSOD 57 thyroid stimulating hormone 57 prostate cancer AIPC 57 antiangiogenesis 57 GLUT4 57 thymosin 57 apoptotic cells 57 ERBB2 57 HIF 1α 57 calcitriol 57 CD# + [002] 57 cdk5 57 hedgehog signaling 57 colorectal polyp 57 lytic 57 CD# protein 57 apigenin 57 fibrogenesis 57 metachronous 57 MAPCs 57 overexpress 57 endothelial progenitor cells 57 atypical hyperplasia 57 VEGF 57 Alu RNA 57 Notch1 56 lung adenocarcinomas 56 lymphomas 56 adipocyte differentiation 56 fibroadenomas 56 G6PD 56 TGF β1 56 GIST tumors 56 XBP1 56 elevated CRP 56 EZH2 56 K ras 56 COX2 56 leukemic blasts 56 TGF beta 56 FGF2 56 beta catenin protein 56 sarcomatoid 56 HCV replication 56 potent stimulator 56 annexin V 56 androgen receptor AR 56 breast endometrial 56 M1 macrophages 56 epithelial tumors 56 precancerous cells 56 carcinoid 56 BRAF mutations 56 TNF α 56 induce apoptosis 56 HDAC2 56 CEACAM1 56 cytokine IL 56 E cadherin 56 ERa 56 caspase activation 56 unresectable tumors 56 ferroportin 56 ER alpha 56 MYCN 56 lipocalin 56 CCL# 56 immunoreactivity 56 interleukin IL -# 56 DHFR 56 HbF 56 neuroblastoma tumors 56 mammary cancers 56 JAK2 56 axillary lymph nodes 56 lymphocyte 56 HIF 1a 56 eosinophil 56 GM CSF granulocyte 56 hCG beta 56 tenascin C 56 K RAS 56 hepatocellular carcinoma 56 TGF b 56 BRAF V#E mutation 56 Yap1 56 cancerous tumors 56 thyroxine T4 56 recurrent glioblastoma multiforme 56 NF kB pathway 56 Smoothened 56 nicotinic acetylcholine receptor 56 plasma kallikrein 56 acinar cells 56 NRG1 56 thyroid carcinoma 56 MMP2 56 alkylating agent 56 ImmuKnow 56 sporadic ALS 56 sortilin 56 uPA 56 Skp2 56 MUC1 * 56 VEGFR1 56 prostate specific antigen 56 chemotherapeutic agent 56 HER2 56 colorectal adenoma 56 NF kappaB 56 endometrial hyperplasia 56 p#INK#a 56 granulocyte 56 tumor progression 56 gamma tocotrienol 56 serum urate levels 56 costimulatory 56 RhoA 56 tumor subtypes 56 orthotopic 56 p# protein 56 basal cells 56 ependymal cells 56 mutated K ras 56 bone resorption 56 polymorphonuclear leukocytes 56 bladder cancers 56 Prostate Specific Antigen PSA 56 CDK8 56 p# mutations 56 synuclein 56 androgen receptors 56 neurite 56 NMIBC 56 CXCR2 56 GSK3 56 breast epithelial cells 56 hypermethylated 56 radiolabeled 56 FGFR3 56 cardiac fibroblasts 56 node metastases 56 BRAF V#E 56 antiangiogenic therapy 56 IGF1R 56 serum calcium 56 N Myc 56 anti inflammatory cytokine 56 TGFß 56 lung fibroblasts 56 pituitary hormones 56 hypervascular tumors 56 chemoresistant 56 primary cilia 56 cervical lymph nodes 56 endometrial tumors 56 soluble receptor 56 colorectal liver metastases 56 neoadjuvant chemotherapy 56 lung carcinomas 56 epididymal 56 Leydig cells 56 renal fibrosis 56 breast cancers 56 mitochondrial respiration 56 Her2/neu 56 Srcasm 56 KRAS status 56 Degarelix 56 remyelination 56 overexpression 56 pyrimidine 56 EGFR tyrosine kinase inhibitors 56 ceramide 56 precancerous lesion 56 neoplastic lesions 56 molecular abnormalities 56 anaplastic lymphoma kinase 56 KRAS oncogene 56 nonsmall cell lung cancer 56 proteoglycan 56 HER2/neu 56 TIMP 56 prostaglandin synthesis 56 p# activation 56 neointimal hyperplasia 56 HER-2/neu 56 microvessel density 56 imetelstat 56 hepatic glucose production 56 epithelial cell 56 CCR9 56 CD# [002] 56 enzymatic activity 56 cyclooxygenase 56 hair follicle stem cells 56 Wnt signaling 56 MAP kinase 56 Th2 cytokines 56 PDGFR alpha 56 neuronal stem cells 56 Wnt beta catenin 56 TRAIL R2 56 FKBP# 56 myeloid derived 56 oral squamous cell 56 transcriptional repressor 56 Cytotoxic T 56 Factor Receptor 56 fibroblast 56 gastric adenocarcinoma 56 epithelial ovarian cancer 56 umbilical vein 56 neointimal 56 Tumours 56 osteocalcin 56 metastatic renal cell carcinoma 56 HIF 1alpha 56 squamous cell carcinoma SCC 56 FDG uptake 56 mitogen 56 PSMA ADC 56 apical membrane 56 nanomolar 56 EGFR signaling 56 advanced adenoma 56 luteolin 56 metastatic cancer 56 phagocytes 56 Tregs 56 anti Neu5Gc antibodies 56 tumorigenic 56 chromosomal aberrations 56 adhesion molecule 56 Wnt pathway 56 prostaglandin E2 56 papillary renal cell carcinoma 56 LHRH receptor positive 56 PSA nadir 55 AAV2 55 RAR beta 55 metastatic prostate 55 ovarian pancreatic 55 pancreatic endocrine 55 disease progression 55 STK# [002] 55 aP2 55 leukocytes 55 CD4 + cells 55 biopsied tissue 55 TACE 55 homodimers 55 Rap1 55 endothelial cell 55 endometrial cells 55 pro inflammatory cytokine 55 Treg cells 55 ZNF# 55 submandibular gland 55 Rac1 55 mononuclear 55 gastrointestinal stromal tumors GIST 55 Carcinoid tumors 55 transcriptional activation 55 ABCB1 55 NK cells 55 superoxide 55 ARF1 55 arginase 55 neural progenitor cells 55 osteosarcomas 55 monocytic 55 SOD2 gene 55 pDC 55 lymphocytosis 55 Src kinase 55 troponin T 55 synovial cells 55 regulated kinase ERK 55 granulocytes 55 HSCs 55 #T# L1 55 molecule epidermal 55 cytokines IL 55 tumor regrowth 55 osteoclast activity 55 Glioma 55 c myc 55 CYC# 55 JAK2 enzyme 55 squamous cell lung cancer 55 serine protease 55 MUC1 55 mTOR 55 HER2 gene 55 renal cell carcinoma 55 fulvestrant 55 oesophageal adenocarcinoma 55 Kupffer cells 55 phosphorylate 55 goblet cells 55 PrPSc 55 P cadherin 55 MALT lymphoma 55 FGF# 55 cyclic adenosine monophosphate cAMP 55 operable breast cancer 55 tubulin polymerization 55 MEK ERK 55 interferon gamma 55 cholesterol absorption 55 Fas ligand 55 metastatic neuroendocrine tumors 55 adenomas 55 alpha fetoprotein AFP 55 metastatic tumor 55 chemotherapeutic drug 55 TGF beta1 55 neutrophils 55 cathepsin B 55 melanoma 55 hormone LHRH 55 HLA DR 55 PDE7B 55 CXCR4 55 Tumor cells 55 Th1 cells 55 Cyclin E 55 KRAS mutations 55 gastric carcinogenesis 55 vascular endothelial 55 tryptase 55 biochemical relapse 55 anti fibrotic 55 NKX2 55 adipogenesis 55 PPAR γ 55 ß catenin 55 leukaemias 55 GSTT1 55 trans retinoic acid 55 uveal melanoma 55 Th# cells 55 prolongs survival 55 apelin 55 menin 55 endothelial nitric oxide 55 EGFR HER2 55 ADAMTS# 55 insulin sensitizing 55 micro RNAs 55 vasodilatory 55 heterodimers 55 CD# expressing 55 alpha#beta# integrin 55 B lymphocyte 55 cytolytic 55 mTORC1 55 tumorigenicity 55 tumor suppressor protein 55 NPD1 55 endocrine tumors 55 DNA adducts 55 DNA methylation patterns 55 bleomycin 55 IDH1 mutation 55 proximal tubules 55 IFN beta 55 HER2 neu 55 insulin secreting cells 55 mTOR signaling 55 triphosphate 55 55 BCL2 55 #F FDG 55 immunodeficient mice 55 CIN2 + 55 cells overexpressing 55 beta islet cells 55 etoposide 55 B7 H4 55 IL #p# 55 TORC2 55 inhibiting COX 55 intestinal polyps 55 normal prion protein 55 55 PGDH 55 NF κB 55 intact parathyroid hormone 55 activating mutations 55 peripheral blood mononuclear 55 Tie2 55 teratoma 55 neurotrophic 55 PIP3 55 mediated immunity 55 ras gene 55 TLE3 55 effector function 55 prostate cancer mCRPC 55 p# Shc 55 salinomycin 55 aneuploid cells 55 biochemical recurrence 55 MCF7 cells 55 distant metastases 55 IFN γ 55 telomerase activity 55 gastric carcinoma 55 inhibitory effect 55 prostate gland 55 Her-2/neu 55 ovarian hormones 55 Mcl 1 55 atypical ductal hyperplasia 55 prostate adenocarcinoma 55 neuroendocrine cancers 55 NFATc1 55 bronchoalveolar lavage fluid 55 podocytes 55 gastric cancers 55 endometrial cancer 55 troponins 55 tumor microenvironment 55 HER3 55 huntingtin 55 mesangial 55 autocrine 55 endothelial cells 55 activated lymphocytes 55 carcinoid tumors 55 recurrent ovarian 55 abiraterone 55 ALDH 55 medulloblastomas 55 osteoblastic 55 P. acnes 55 histone acetylation 55 tumor antigen 55 cofilin 55 cardiomyocyte 55 NKG2D 55 chemokine receptor 55 natriuretic peptide 55 lobular breast cancer 55 MMPs 55 preoperative chemotherapy 55 endometrial 55 fibroblast cells 55 tumor biopsies 55 carotid plaque 55 Tissue Factor 55 effector memory 55 hyperactivated 55 focal adhesion kinase FAK 55 mesothelial cells 55 estrogen receptor negative 55 acinar 55 bone morphogenetic proteins 55 β catenin 55 estrogen metabolites 55 gut mucosa 55 mitogen activated protein kinase 55 eIF 4E 55 infarct size 55 mutated protein 55 ERK pathway 55 premalignant 55 urate 55 EphB2 55 myo inositol 55 hematopoietic cell 55 NEDD9 55 aromatase enzyme 55 antitumor 55 liver fibrosis 55 IGFBP2 55 oncogene 55 invasive ductal 55 dephosphorylation 55 fatty plaques 55 cyclic AMP 55 SIRT2 55 PARP inhibitor 55 CaM kinase 55 cells hESCs 55 phosphorylated 55 FGFs 55 cutaneous melanoma 55 monocyte chemoattractant protein 55 inhibit angiogenesis 55 pancreatic carcinoma 55 H#K#me# 55 cancerdefine 55 HER1 55 spermatogenesis 55 B7 H1 55 Wnt signaling pathway 55 HDACs 55 adjuvant radiation 55 dermal papilla cells 55 amyloid plaque formation 55 HSP# 55 nanobees 55 NKCC1 55 naturally occurring molecule 55 CCR1 55 matrix metalloproteinase 55 Endometrial 55 antibody mediated 55 extracapsular extension 55 tumor suppressor proteins 55 TIMP 1 55 pro apoptotic proteins 55 senescent cells 55 Ras pathway 55 oncogenic 55 MAPK pathway 55 methylated DNA 55 glutamate receptors 55 neoadjuvant 55 E cadherin expression 55 mutant huntingtin 55 VEGF induced 55 malignant pleural mesothelioma 55 leukemia CLL 55 CD8 cells

Back to home page